We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$180B
AUM Growth
+$20.4B
Cap. Flow
+$6.1B
Cap. Flow %
3.39%
Top 10 Hldgs %
26.13%
Holding
7,254
New
260
Increased
3,541
Reduced
2,314
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 8.85%
2 Healthcare 5.77%
3 Financials 5.26%
4 Consumer Discretionary 4.71%
5 Communication Services 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSDO
7026
DELISTED
Presidio, Inc. Common Stock
PSDO
-111,617
Closed -$1.89M
ASNA
7027
CALL
DELISTED
Ascena Retail Group, Inc.
ASNA
-1,885
Closed -$10K
ASNA
7028
DELISTED
Ascena Retail Group, Inc.
ASNA
-6,910
Closed -$37K
ASNA
7029
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
-130
Closed -$1K
ONCE
7030
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-95,436
Closed -$9.26M
FTNW
7031
DELISTED
FTE Networks, Inc.
FTNW
$0 ﹤0.01%
+5
New +$7
SNNA
7032
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$0 ﹤0.01%
65
VSI
7033
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
-1,200
Closed -$8K
VSI
7034
DELISTED
Vitamin Shoppe Inc.
VSI
-137,184
Closed -$895K
ROAN
7035
DELISTED
Roan Resources, Inc.
ROAN
-65,434
Closed -$81K
STI
7036
CALL
DELISTED
SunTrust Banks, Inc.
STI
-62,000
Closed -$4.27M
STI
7037
DELISTED
SunTrust Banks, Inc.
STI
-733,849
Closed -$50.5M
STI
7038
PUT
DELISTED
SunTrust Banks, Inc.
STI
-13,700
Closed -$943K
SEMG
7039
DELISTED
SEMGROUP CORPORATION
SEMG
-212,036
Closed -$3.47M
CBM
7040
DELISTED
Cambrex Corporation
CBM
-82,442
Closed -$4.91M
VIAB
7041
CALL
DELISTED
Viacom Inc. Class B
VIAB
-159,200
Closed -$3.83M
VIAB
7042
DELISTED
Viacom Inc. Class B
VIAB
-1,907,358
Closed -$45.8M
VIAB
7043
PUT
DELISTED
Viacom Inc. Class B
VIAB
-307,200
Closed -$7.38M
DNBF
7044
DELISTED
DNB Financial Corp
DNBF
-1,788
Closed -$79K
ORIT
7045
DELISTED
Oritani Financial Corp. New
ORIT
-117,289
Closed -$2.08M
OLBK
7046
DELISTED
Old Line Bancshares, Inc.
OLBK
-9,962
Closed -$289K
AVDR
7047
DELISTED
Avedro, Inc Common Stock
AVDR
-14,795
Closed -$336K
NVTR
7048
DELISTED
Nuvectra Corporation Common Stock
NVTR
$0 ﹤0.01%
+14
New +$17
MCRN
7049
DELISTED
Milacron Holdings Corp.
MCRN
-143,881
Closed -$2.4M
DOVA
7050
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
-13,638
Closed -$381K

Similar funds

Barclays's Q4 2019 Portfolio in Review

As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.

  • Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
  • Barclays added most to Apple in Q4 2019, an estimated $572M increase.
  • Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
  • Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
  • Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
  • Barclays opened 260 new positions and closed 700 in Q4 2019.
  • Barclays's portfolio value rose 13% quarter-over-quarter to $180B.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.